首页> 美国卫生研究院文献>other >Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised double-blind phase 3 clinical trial

【2h】

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised double-blind phase 3 clinical trial

机译：经肿物切除加放疗（NSABP B-35）治疗的绝经后原位导管癌绝经后患者使用阿那曲唑和他莫昔芬的疗效报告：一项随机双盲3期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 other
作者
Patricia A Ganz; Reena S Cecchini; Thomas B Julian; Richard G Margolese; Joseph P Costantino; Laura A Vallow; Kathy S Albain; Patrick W Whitworth; Mary E Cianfrocca; Adam M Brufsky; Howard M Gross; Gamini S Soori; Judith O Hopkins; Louis Fehrenbacher; Keren Sturtz; Timothy F Wozniak; Thomas E Seay; Eleftherios P Mamounas; Norman Wolmark;
展开▼
作者单位

展开▼
年(卷),期 -1(387),10021
年度 -1
页码 857–865
总页数 19
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献

1. 单发肝细胞癌合并微血管侵犯患者根治性切除术后辅助经导管动脉化疗栓塞治疗的疗效和安全性:一项随机临床试验 [J] . Wei Wei, Lie Zheng, Min-Shan Chen, 癌症（英文版） . 2019,第003期
2. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial [J] . Ganz Patricia A., Cecchini Reena S., Julian Thomas B., The Lancet . 2016,第10021期

机译：患者报告的患有Anstrozole与Tamoxifen的后代患者对导管癌的患者的原位治疗（NSABP B-35）：随机，双盲，第3期临床试验
3. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial [J] . Ganz Patricia A., Cecchini Reena S., Julian Thomas B., The Lancet . 2016,第10021期

机译：经肿物切除加放疗（NSABP B-35）治疗的绝经后原位导管癌绝经后患者使用阿那曲唑和他莫昔芬的疗效报告：一项随机，双盲，3期临床试验
4. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial [J] . Margolese Richard G., Cecchini Reena S., Julian Thomas B., The Lancet . 2016,第10021期

机译：Anstrozole与毒素在绝经后妇女的患者，导管癌原位肿瘤切除术加放射治疗（NSABP B-35）：随机，双盲，第3期临床试验
5. Primary results NSABP B-35/NRG Oncology: A clinical trial of anastrozole vs tamoxifen in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy A randomized clinical trial [O] . Richard Margolese, Reena S. Cecchini, Thomas B. Julian, -1

机译：主要结果NSABP B-35 / NRG肿瘤学：阿那曲唑与他莫昔芬在绝经后DCIS接受肿块切除加放疗的患者中的临床试验一项随机临床试验
6. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial [O] . Patricia A Ganz, Reena S Cecchini, Thomas B Julian, 2016

机译：患者报告的患有Anstrozole与Tamoxifen的后代患者对导管癌的患者的原位治疗（NSABP B-35）：随机，双盲，第3期临床试验

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised double-blind phase 3 clinical trial

著录项

相似文献

相关主题

期刊订阅